AI Alert Suppression May Redistribute, Not Eliminate, Medication Risk

This editorial reframes AI-enabled prescription verification as a governance and human-factors problem for medication safety pharmacists, arguing that algorithmic silence should not be equated with clinical safety.

📅 Journal publication: Feb 2026 (online Feb 9, 2026) · Last updated: Oct 6, 2026

artificial intelligenceclinical decision supportprescription verificationautomation biasmedication safetydata driftAI governanceeditorialhigh-alert medications Medication Safety

Background Information

AI governance enhances safety in prescription verification.

AI in prescription verification can significantly improve medication safety by reducing errors and ensuring accurate dispensing. The study outlines AI governance structures and responsible use protocols that enhance safety in prescription verification processes. Understanding governance and responsibility in AI-enabled systems is critical for integrating these technologies into pharmacy practice safely and effectively. Robust AI governance in prescription verification boosts medication safety and accuracy.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Zavaleta-Monestel E, Mora-Jiménez J, Arguedas-Chacón S

Citation: Zavaleta-Monestel E, Mora-Jiménez J, Arguedas-Chacón S When Silence Signals Safety: Governance and Responsibility in AI-Enabled Prescription Verification. Cureus. 2026;18(2):e103272. doi:10.7759/cureus.103272

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →